The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
Citation
Hagström, H., Adams, L. A., Allen, A. M., Byrne, C. D., Chang, Y., Duseja, A., Grønbæk, H., Ismail, M. H., Jepsen, P., Kanwal, F., Kramer, J., Loomba, R., Mark, H. E., Newsome, P. N., Rinella, M. E., Rowe, I. A., Ryu, S., Sanyal, A., Schattenberg, J. M., Serper, M., … Lazarus, J. V. (2024). The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatology communications, 8(2), e0386. https://doi.org/10.1097/HC9.0000000000000386Abstract
Background:Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and advocacy.Methods:Through a two-stage Delphi process, a core group (n = 20) reviewed draft statements and recommendations (n = 6), indicating levels of agreement. Following revisions, this process was repeated with a large expert panel (n = 243) from 73 countries.Results:Consensus ranged from 88.8% to 96.9% (mean = 92.3%).Conclusions:This global consensus statement provides guidance on harmonizing the International Classification of Diseases coding for steatotic liver disease and future directions to advance the field.
